Quickly
Socially
Trending
CryptoCOVID 19 VACCINE
Oxford-AstraZeneca COVID-19 Vaccine: NIH 'Very Concerned' About Side-Effect on UK Trial Participant, Suspects Case of 'Transverse Myelitis'
COVID-19 Vaccine Update: Novavax Inc Extends Pact With Serum Institute, Will Now Produce 200 Crore Coronavirus Vaccine Doses
COVID-19 Vaccine in India Update: Serum Institute to Start Phase 3 Trials of Oxford Candidate After Clearances, Says ICMR
Sputnik V Vaccine Update: Over 300 Volunteers Get Russian COVID-19 Vaccine, 14% Have Minor Complaints
COVID-19 Vaccine Latest News Update: Anti-Coronavirus Vaccines Being Developed in China May Be Ready For Public by November or December, Says Senior Official
Pfizer COVID-19 Vaccine Can be Given to Americans by 2020-End if Granted FDA Nod by October, Says CEO Albert Bourla
COVID-19 Vaccine For Everyone Not Possible Before 2024, Says Serum Institute of India Chief Adar Poonawalla
Coronavirus Vaccine Could Be Ready By First Quarter of 2021, Would Volunteer For Receiving COVID-19 Drug To End Trust Deficit, Says Health Minister Harsh Vardhan
Oxford-AstraZeneca's COVID-19 Vaccine Trials Resumes in UK After Brief Pause Over Volunteer's Illness
COVID-19 Vaccine: Serum Institute to Resume Trials of Oxford-AstraZeneca Candidate After DCGI Nod
Oxford-AstraZeneca's COVID-19 Vaccine Trials in UK to Resume After Brief Pause Over Volunteer's Illness
COVID-19 Vaccine Update: Animal Study of Coronavirus Vaccine Candidate Covaxin Were Successful, Says Bharat Biotech
China Approves First Nasal Spray COVID-19 Vaccine for Phase One Clinical Trials in November 2020
COVID-19 Vaccine Update: DCGI Sends Show Cause Notice to Serum Institute of India for Not Pausing Trial of Covishield
Arvind Kejriwal Allows RT-PCR COVID-19 Tests Without Prescription In Delhi, Vaccine ‘Sputnik V’ To Be Tested In India, Says Russian Media
COVID-19 Vaccine Update: Clinical Trials of Oxford's Covishield Will Continue in India, Says Serum Institute of India After AstraZeneca Puts Trials on Hold in UK
COVID-19 Vaccine Update: Oxford-AstraZeneca Coronavirus Vaccine Trial 'Voluntarily Paused' After Unexplained Illness in Volunteer
Google Trends
Live Bot